For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...

The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 ...

As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.

A breakthrough has made photodynamic therapy safer and more effective. Scientists have developed new light-sensitive chemicals that could significantly enhance the treatment of aggressive cancers ...

Chlorination is a widely used method to disinfect drinking water, but new research suggests its byproducts may pose cancer ...

Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...

Jordie Poncy was diagnosed with a rare form of cancer just as he was preparing to start a new counseling job at Moffitt ...

Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a look at where CG Oncology, Inc.

Medical experts emphasize the significance of early cancer detection. Learn about seven crucial warning signs that could ...